This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Influenza A H18N11 Neuraminidase (NA), C-His
Product Overview
BioVenic's Recombinant Influenza A H18N11 Neuraminidase (NA), C-His is a recombinant protein expressed from Mammalian Expression System. Its predicted molecular weight is 48.5 kDa. The purity is>90% (SDS-PAGE).
Specifications
Target Information
N11 is a highly divergent neuraminidase-like (NAL) glycoprotein from the bat-derived H18N11 influenza virus. Structurally, it retains the typical tetrameric, box-shaped architecture of canonical neuraminidases (N1-N9), but functionally, it lacks detectable sialidase activity. Its active site is wider and lacks the conserved amino acids required to bind or cleave sialic acid. Emerging research suggests that N11 is not essential for viral release in certain models but may influence viral fitness, tissue tropism, and potential adaptation to mammalian hosts through non-enzymatic mechanisms.
Shipping and Storage
This product is shipped with gel ice bags. Avoid repeated freezing and thawing. Store for 12 months at -20°C or -80°C.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.